Skip to main content
Top
Published in:

01-12-2025 | Brain Tumor | Review

Chronic Neurological Complications of Brain Tumors and Brain Tumor Treatments

Authors: Jigisha P. Thakkar, Diego D. Luy, Andrew Pickles, Tamer Refaat, Vikram C. Prabhu

Published in: Current Neurology and Neuroscience Reports | Issue 1/2025

Login to get access

Abstract

Purpose of Review

Chronic complications of brain tumors and brain tumor treatments can lead to impairment of health-related quality of life and decreased functionality. These largely include cognitive decline, fatigue, headache, seizures, and secondary malignancies. Outpatient neurologists are an integral part of the multidisciplinary neuro-oncology team who help diagnose and manage chronic complications in this complex patient population. Timely diagnosis and treatment of these complications in outpatient neurology and neuro-oncology clinics helps improve quality of life and survival of brain tumor patients.

Recent Findings

We discuss updated information and management regarding various chronic neurologic complications among neuro-oncology patients.

Summary

Understanding of chronic neurologic complications associated with central nervous system tumors and with common contemporary cancer treatments will facilitate neurologists management of these patient populations. While there are aspects analogous to the diagnosis and management in the non-oncologic population, a number of unique features discussed in this review should be considered.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Chronic Neurological Complications of Brain Tumors and Brain Tumor Treatments
Authors
Jigisha P. Thakkar
Diego D. Luy
Andrew Pickles
Tamer Refaat
Vikram C. Prabhu
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 1/2025
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-025-01411-z

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest